All the manufacturers and marketing companies are required to revise the MRP of drugs/formulations on which Tax/GST rates have been reduced taking into effect the revised rates of Tax/GST.(18.06.2021)

All the manufacturers and marketing companies are required to revise the MRP of drugs/formulations on which Tax/GST rates have been reduced taking into effect the revised rates of Tax/GST. Recalling or re-labelling or re-stickering on the label of container or pack of released stocks in the market prior to date of notifications, is not mandatory, if manufacturers are able to ensure price compliance at the retailer level through issuance of a revised price list.

[Circular of Department of Pharmaceuticals File No. 19(175)/2019/DP/NPPA/Div. II dtd 15th June 2021]

Leave a Comment

Your email address will not be published. Required fields are marked *